Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
59 participants
OBSERVATIONAL
2022-06-01
2024-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
CD64 Measurement in Neonatal Infection and Necrotising Enterocolitis
NCT01005589
Administration of Arginine Supplementation in Preterm Infants
NCT01336998
Epidemiology, Treatment and Prognosis of Neonatal Meningitis in Turkey: A Multicenter Study
NCT04009551
Neutrophil CD64 for Early Diagnosis of Nosocomial Infection in Preterm Newborns
NCT01951781
Procalcitonin for Predicting Serious Bacterial Infection in Infants Less Than 3 Months
NCT00800488
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Premature infants diagnosed with stage 2 and stage 3 NEC and a matched control group.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
3 Days
30 Days
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ankara Yildirim Beyazıt University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sara EROL
Assoc Prof, MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Abdullah Kurt
Role: STUDY_DIRECTOR
Ankara Yildirim Beyazıt University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ankara Bilkent City Hospital
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Erol S, Tayman C, Korkut S, Cakir U, Kurt A, Koyuncu I. A comparative study of serum and fecal calprotectin levels in necrotizing enterocolitis. J Pediatr (Rio J). 2025 Sep-Oct;101(5):101428. doi: 10.1016/j.jped.2025.101428. Epub 2025 Aug 21.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
26379996/26, 03-2022
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.